Aim: The receptor for advanced glycation endproducts (RAGE) expression has been reported to be implicated with cancer development. In this study, the role of RAGE in the regulation of cervical squamous cancer cell proliferation, apoptosis and the mechanism of RAGE involved in the biological behaviors were explored. Methods: The RAGE expression was overexpressed or downregulated by lentivirus transfection. The effect of RAGE expression on cell proliferation was explored by CCK-8, MTT, and BrdU assay, and the effect of RAGE on tumor development was confirmed by the xenograft mouse model along with the immunohistochemistry stain of proliferating cell nuclear antigen (PCNA). Apoptosis was investigated by flow cytometry and TUNEL assay. Western blotting was performed to investigate the expression of possible proteins, including Bax, Bcl-2, PI3K, p-PI3K, AKT, and p-AKT. Results: Overexpression of RAGE promoted proliferation of cervical squamous cancer cell and increased PCNA expression. In the meantime, RAGE overexpression inhibited cell apoptosis along with a decrease of Bax/Bcl-2 ratio, and induction of PI3K/AKT activation. The in vivo results showed that overexpression of RAGE enhanced tumor growth. Conversely, knockdown of RAGE exhibited opposed effects on cervical cancer cells and xenograft mouse model. Furthermore, RAGE inhibitor FPS-ZM1 effectively inhibited SiHa cell viability and PCNA expression, and increased cell apoptosis and Bax/Bcl-2 ratio. Moreover, PI3K inhibitor LY294002 effectively inhibited activation of PI3K and AKT, and further repressed RAGE overexpression-induced cell proliferation and apoptosis inhibition. Conclusion: RAGE promotes the growth ability of cervical squamous cell carcinoma by inducing PCNA expression and inhibiting cell apoptosis via inactivation of the PI3K/AKT pathway.
Introduction
Cervical cancer is a major cause of cancer-related death among women in the United States, with estimated 13,170 new cases and 4250 patients will die due to this disease in 2019. 1 Accumulated evidence has supported the assumption that inflammation plays an important role in tumorigenesis. 2, 3 In line with this notion, persistent infection of human papillomavirus (most notably HPV16 and HPV18) in the cervix has been definitely defined as a major cause of cervical tumorigenesis, 4 suggesting that inflammatory response may be tightly involved in development and progression of cervical cancer. However, the underlying mechanism of inflammation-induced cervical carcinogenesis has not been fully elucidated.
The receptor for advanced glycation end products (RAGE) initially discovered in 1992, is a member of the immunoglobulin superfamily with multiple extracellular ligands. 5 RAGE is implicated in the pathogenesis of various inflammatory disorders and is believed to activate multiple intracellular signaling mechanisms that fuel chronic inflammatory conditions leading to malignant transformation. [6] [7] [8] [9] The pivotal role of RAGE in pathophysiological processes suggests that this receptor is an attractive target for therapeutic interventions. Indeed, recent studies provide evidence that RAGE is up-regulated in many malignant tumors including breast, lung, pancreatic, prostate, colorectal, gastric, and liver cancers. [10] [11] [12] [13] [14] The elevated level of RAGE protein has also been detected in a set of cancers, which is associated with increased tumor histological grade and poorer outcomes. 12, [15] [16] [17] [18] Biochemically, RAGE interacts with a broad spectrum of ligands and induces a number of malignant processes including increased cell proliferation, metastasis, and decreased apoptosis. 10, 11, 13, 14, 19, 20 Notably, our previous study reported that RAGE was upregulated in tissues from chronic cervicitis, cervical intraepithelial neoplasia (CIN), and squamous cervical cancer (SCC) by using immunohistochemical analysis. Moreover, the expression of RAGE was gradually increased as the tumor was progressed, indicating the potential oncogenic role of RAGE in cervical squamous cancer. 21 In spite of these exciting discoveries, the precise role of RAGE in cervical squamous cancer proliferation and apoptosis is unclear.
Therefore, this study explored the effects of RAGE on cell viability and apoptosis in cervical squamous cancer cells. We also explored the possible mechanisms underlying RAGE involved cell proliferation and apoptosis. Moreover, we investigated the proliferation and apoptosis behavior of SiHa cells exposed to RAGE inhibitor FPS-ZM1, which is a high-affinity but nontoxic RAGE-specific inhibitor that has been recently shown to attenuate the Aβinduced inflammatory response by blocking the ligation of Aβ to RAGE. 17 The aim of the present study was to establish the possible role of RAGE and the related signaling pathway in cervical cancer progression to illustrate the emerging and preliminary attempts to target RAGE as a novel strategy for cancer treatment.
Materials and Methods

Antibodies and Reagents
Antibodies to PCNA, Bax, Bcl-2, Akt, p-AKT, PI3K, p-PI3K, GFP, and PI3K/AKT inhibitor LY294002 were purchased from Cell Signaling Technology (Beverly, USA 
Cell Culture and Treatment
Human cervical cancer cell lines SiHa, CaSki, C33A and MS751 were purchased from Shanghai Cell Biology Medical Research Institute, Chinese Academy of Sciences. SiHa, C33A and MS751 cells were maintained in DMEM (Invitrogen, NY, USA) and CaSki cells were cultured in RPMI-1640 (Invitrogen, NY, USA) containing 10% fetal bovine serum (FBS), 1% penicillin and streptomycin at 37°C in a 5% CO 2 incubator. Cells were digested by rinsing with 0.05% trypsin and then cultured for 24 h for further treatment.
Construction of Lentivirus
Human GFP-RAGE cDNA was subcloned into pLenti-C-mGFP vector (Origene, MD, USA) and shRAGE to pLKO.1-TRC vector (Origene, MD, USA) in vitro. The pLenti-C-mGFP vector (Vector) or pLKO.1-TRC vector (NC) without GFP-RAGE cDNA or shRAGE was used as an empty vector control. And cells treated with lipofectamine 2000 were used as blank control (Control). After confirmation using gene sequencing, virus was packed using 293T cells with two packaging vectors psPAX2 and pMD2.G. Lentiviral particles were harvested and filtered to infect cervical cancer cell lines.
ELISA Assay
The quantification of RAGE in the medium of different cervical squamous cancer cells was performed with an ELISA Kit for human RAGE according to the manufacturers' protocol. In brief, 5×10 5 SiHa, CaSki, C33A and MS751 cells were incubated for 12, 24, 36, 48, and 72 hrs. The growth medium at each time point was harvested and the concentration of RAGE was measured by the Multiskan GO (Thermoscientific) at 450 nm wavelength. The experiment was repeated three times.
MTT Assay
The viability of cervical cancer cells was determined by MTT assay. In brief, cells (3000/well) were seeded 100 μL of medium/well in 96-well plates. After overnight incubation, 10 μL MTT solution was added to each well and incubated at 37°C for another 4 hrs in a humidified incubator, then removed the liquid and added 100 μL/well DMSO, absorbance was measured at 570 nm using Microplate Reader. The experiment was repeated three times.
Cell Counting Kit 8 (CCK-8) Assay
CCK-8 assay was also used to determine the proliferation ability. In brief, cells were seeded into 96-well plates at a density of 3000 cells per well. After overnight incubation, the medium was replaced with various concentrations of FPS-ZM1 (0, 0.5, 1, 2, 4, 8 μmol/L) for the next 24, 48 and 72 hrs. The following day, the medium was washed using PBS; then, 10 μL of the CCK-8 reagent was added to each well and incubated at 37°C for 2 h. The absorbance value was measured at 450 nm wavelength using a Microplate Reader. The experiment was repeated three times.
BrdU Assay
Cells were cultured under optimum growing conditions on the glass. Added BrdU at a final concentration of 30 μg/ mL and incubated for 12 hrs. Removed BrdU medium, rinsed thrice with PBS and incubated with 3% H 2 O 2 for 10 mins. Fixed the cells with 4% paraformaldehyde for 20 mins and rinsed thrice with PBS. Added 2 mol/L HCl and incubated at 37°C for 5 mins and rinsed thrice with PBS. Incubated cells with 0.2% Triton ×100 for 20 mins in room temperature, afterward blocked in 3% BSA for 30 mins at room temperature. Added 100 μL/glass diluted α-BrdU (Mouse mAb) and stored at 4°C overnight. Rinsed the cells thrice with PBS and added 100 μL diluted Goat anti-Mouse, incubated 1 hr at room temperature. Rinsed thrice with PBS and stained with DAB, hematoxylin for a probable time, observed under a microscope with 200× magnification. The experiment was repeated three times.
Flow Cytometry Analysis
Cells were plated at 5×10 5 cells/dish into 60-mm dishes. After appropriate treatment and incubation, cells were harvested, washed with cold PBS, and resuspended with binding buffer at a concentration of 1×10 6 cell/mL. Then, the cells were double-stained with annexin V-FITC/propidium iodide or PE/7-AAD according to the manufacturer's protocol (BD Pharmingen, CA, USA). The percentage of apoptotic cells were detected by flow cytometry after staining. The experiment was repeated three times.
TUNEL Assay
For cells: Culture cells were under optimum growing conditions on the glass. After incubation for 24 hrs, rinsed thrice with PBS and fixed the cells with 4% paraformaldehyde for 30 mins and rinsed thrice with PBS. Incubated cells with 0.3% Triton×100 for 5 mins in room temperature, afterward incubated with TUNEL detection solution for 1 hr. Rinsed the cells thrice with PBS and added DAPI solution, and incubated 2 mins at room temperature. Rinsed thrice with PBS and observed under a fluorescence microscope with 200× magnification.
For tissues: The slices were dewaxed and washed by PBS thrice. Then, incubated with 0.1% Triton×100 for 5 mins. Afterward, slices were incubated with prepared TUNEL solution for 1 hr at 37°C in dark. DAPI solution was used for nuclear staining at 37°C for 2 mins. Slices were observed using a fluorescence microscope (magnification, ×200).
Immunohistochemistry
After fixation, samples were paraffin-embedded and sliced. The sections were microwaved for antigen retrieval and incubated with Mouse mAb PCNA primary antibody diluted at a ratio of 1 to 200 overnight at 4°C. Then, the sections were washed with PBS, incubated with Goat anti-Mouse secondary antibody for 15 mins, and allowed to perform a chromogenic reaction using a DAB Substrate Kit for color development at room temperature. Then, sections were counterstained with hematoxylin. Representative images of tumor tissues were captured using a Leica microscope.
Western Blotting Analysis
Samples were homogenized and lysed in Radio Immunoprecipitation Assay buffer with a cocktail of protease inhibitors. The total protein concentrations were quantified by the bicinchoninic acid protein assay (Thermo Scientific, IL, USA). Equal amounts of total protein were resolved by sodium dodecyl sulfate PAGE, transferred to a nitrocellulose membrane under constant voltage and blocked with Tris-buffered saline with Tween (TBST) containing 5% non-fat dried milk. Primary antibodies (Mouse mAb PCNA, Rabbit mAb Bax, Bcl-2, Akt, p-AKT, PI3K, p-PI3K and GFP diluted at a ratio of 1to 1000. Mouse mAb RAGE and GAPDH diluted at a ratio of 1 to 5000 and secondary antibodies were diluted in TBST and applied with a washing step between primary and secondary antibodies' incubation. Proteins were detected using the Amersham ECL Western blotting detection kit (GE Healthcare, NJ, USA).
Tumor Xenograft Model
Female BALB/c (nu/nu) mice (4-5 weeks of age; Laboratory Animal Resources, Chinese Academy of Sciences) were group-housed under a constant photoperiod of 12 h light and 12 h dark, and were provided with sterilized food and water. Ethical and legal approval was obtained prior to the commencement of the animal study. All experimental procedures using live animals were conducted in accordance with protocols approved by the Wenzhou Medical University Institutional Animal Care and Use Committee and national guidelines and regulations. On the basis of lentivirus system which can stably upregulate or downregulate RAGE in cervical cancer cell lines, xenograft tumors were established by subcutaneously injecting SiHa cells transfected with GFP-RAGE (1× 10 6 cells/mouse) or RAGE-KD (5 × 10 6 cells/mouse) in a total volume of 0.1 mL in PBS. Tumor volumes were calculated from caliper measurements. In detail, the long and short diameters of tumor were measured and then were calculated by the standard formula of volume = (Long diameter×Short diameter×Short diameter)/2. Upon terminal sacrifice, the tumors were harvested, snap-frozen in liquid nitrogen, and stored at −80°C until use to Western Blot for biomarkers and TUNEL for apoptosis detection.
Statistical Analysis
All the statistical analysis was performed with SPSS 17.0 statistical software (Chicago, USA). Data are expressed as mean ± standard deviations. All experiments were performed at least in triplicate. Two-tailed Student's t-test was used to analyze differences between groups and Oneway ANOVA was used to analyze differences among groups (more than two groups) when the data were normally distributed. Levene test was used for homogeneity test of variance, and the LSD was performed for homogenous data, while Dunnett's T3 was performed for heterogeneous data. P <0.05 was considered to be statistically significant.
Results
RAGE Is Both Expressed and Secreted by Human Cervical Cancer Cells
The intracellular expression level of RAGE protein in four different cervical squamous cancer cell lines including SiHa, CaSki, C33A and MS751 was investigated. Western blotting analysis data showed that RAGE was expressed in all cervical cancer cell lines ( Figure 1A) . Notably, the RAGE protein level was the highest in SiHa cells whereas it is the lowest in CaSki cells ( Figure 1A) . Subsequently, the extracellular expression of RAGE in four cervical squamous carcinoma cells was also detected. The results of ELISA showed that the concentration of RAGE protein was significantly increased in a time-dependent manner in the supernatants of all cell lines, among which SiHa cells exhibited the highest extracellular RAGE expression. Consistently, the lowest concentration of RAGE protein was also observed in the supernatant of CaSki cells ( Figure 1B) . Collectively, these results indicated that RAGE protein was both expressed in cervical squamous cancer cells and secreted by these cells.
Inhibition of RAGE Expression by FPS-ZM1 Suppresses the Proliferation and Promotes the Apoptosis of SiHa Cells
According to the results above, SiHa cells were selected to investigate the effect of RAGE expression on the proliferation and apoptosis of cervical squamous cancer cells. The specific RAGE inhibitor FPS-ZM1 was employed herein. Application of FPS-ZM1 dose-and timedependently reduced SiHa cells viability along with the downregulation of proliferative protein PCNA (P <0.05; Figure 1C and D). In addition, the apoptosis of SiHa cells was significantly induced by 1 μM FPS-ZM1 as compared with the control group (P <0.05; Figure 1E ). In keeping with this result, FPS-ZM1 dramatically enhanced Bax/Bcl-2 ratio in a dose-dependent fashion (P <0.05; Figure 1E and F).
Cervical Squamous Cell Lines with RAGE Overexpression and Knockdown are Constructed via Lentivirus Infection
On the basis of RAGE expression in four wild type cervical squamous cell lines, SiHa and CaSki cells were stably 
DovePress
OncoTargets and Therapy 2020:13
transfected with GFP-RAGE to overexpress RAGE, while SiHa cells were chosen to construct RAGE knockdown cells through RAGE-KD plasmid lentiviral infection. The GFP-green fluorescence was observed to determine the RAGE expression in both cell lines by fluorescence microscope. The protein levels of GFP-RAGE or RAGE were determined in SiHa and CaSki cells by Western blotting. Both SiHa and CaSki cells transfected with GFP-RAGE plasmid displayed strong fluorescence signal, which indicated that RAGE was overexpressed successfully in these two cell lines. When compared with empty vector groups, a significantly higher level of GFP-RAGE was found in both SiHa and CaSki cells transfected with GFP-RAGE (P <0.05; Figure 2A and B) . On the contrary, SiHa cells transfected with RAGE-KD plasmid exerted a lower RAGE expression than the negative control (NC) group (P <0.05; Figure 2C ). Then, these cell lines were utilized in further experiments.
Overexpression of RAGE Promotes SiHa and CaSki Cells Proliferation
Next, the effect of RAGE expression on the proliferation behavior of SiHa and CaSki cells by MTT and BrdU assays were detected. The MTT results showed that overexpression of RAGE significantly promoted cell proliferation in both SiHa and CaSki cells, as compared with the vector group (P <0.05; Figure 3A) . Similarly, BrdU results revealed thicker nuclear stain dots in the RAGE overexpression group of both SiHa and CaSki cells than that in the vector group (P <0.05; Figure 3B ). In addition, significant upregulation of PCNA protein in both cells with RAGE overexpression further confirmed the promotive effect of RAGE in cell proliferation (P <0.05; Figure 3C ). Conversely, shRNA mediated-RAGE knockdown in SiHa cells significantly inhibited cell proliferation by MTT and BrdU assays (P <0.05; Figure 3D and E), which was further verified by the downregulation of PCNA (P <0.05; Figure 3F ).
Overexpression of RAGE Inhibits SiHa and CaSki Cell Apoptosis
We further detected the effect of RAGE expression on apoptosis SiHa and CaSki cells in vitro, using the flow cytometry assay and TUNEL assays. As a result, RAGE overexpression decreased the apoptotic rates of both SiHa and CaSki cells as compared to vector groups (P <0.05; Figure 4A and B). In addition, TUNEL results showed RAGE overexpression decreased cell apoptosis in both cell lines ( Figure 4C and D) . Furthermore, Western blotting data revealed that RAGE overexpression induced the downregulation of Bax and activation of Bcl-2, leading to the decrease of Bax/Bcl-2 ratio (P <0.05; Figure 4E ). Contrarily, shRNA mediated-RAGE knockdown increased the apoptosis percentage in SiHa cells with an increase of Bax/Bcl-2 ratio compared with the corresponding control group (P <0.05; Figure 4F and G).
Overexpression of RAGE Promotes the Tumor Growth and Inhibits the Apoptosis of Cervical Cancer Cells in vivo
A SiHa cells xenograft mouse model was established and used to explore the influence of RAGE on the growth and apoptosis of cervical squamous cancer. Compared with vector group, mice injected with RAGE-overexpression SiHa cells showed high proliferative activity in the tumor volume from 6 weeks onward (P <0.05; Figure 5A ). Further immunohistology analysis also detected more abundant PCNA expressions in the xenograft tumor tissue after RAGE upregulation (P <0.05; Figure 5B ). In the meantime, TUNEL assay demonstrated that RAGE 
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OncoTargets and Therapy 2020:13 overexpression significantly inhibited the apoptosis of SiHa cell xenografts ( Figure 5C ). Oppositely, the tumor volume was significantly decreased at the beginning of 4 weeks in RAGE-KD SiHa cell xenograft mice compared with the NC group in vivo, along with downregulation of PCNA (P <0.05; Figure 5D and E). In addition, RAGE knockdown induced tumor tissue apoptosis detected by TUNEL assay (Figure 5F ).
PI3K/AKT Is Involved in RAGE Expression-Related Apoptosis
To clarify the underlying pathway of RAGE in cervical squamous cancer development, the PI3K/AKT signaling pathway was analyzed. Western blotting analysis demonstrated that PI3K/AKT was activated by RAGE overexpression (P <0.05; Figure 6A ) and suppressed after RAGE knockdown (P <0.05; Figure 6B ) in SiHa cells, respectively. A specific inhibitor of PI3K (LY294002), which also effectively inhibits AKT phosphorylation, was added to the SiHa cells supernatant with RAGE overexpression, resulting in increased cell apoptosis (P <0.05; Figure 6C ). Consistent with this, activation of PI3K/AKT by RAGE overexpression was reversed by LY294002 along with the downregulation of PCNA and upregulation of Bax/Bcl-2 ratio ( Figure 6D ). These findings showed that activation of the PI3K/AKT was essential for RAGE to inhibit cervical cancer cell apoptosis.
Discussion
RAGE is a central core of a multi-ligand signaling system that drives innate immune-inflammatory responses. 22 Ligand binding to RAGE induces a sustained activation and overexpression of RAGE, which leads to prolonged inflammatory reactions and plays a causative role in human cancers. 10, 23 In this work, we identified that RAGE acted as an oncogenic role in cervical squamous cancer and PI3K/AKT pathway was responsible for RAGE-mediated cervical squamous cancer progression.
In fact, the expression of RAGE is extremely low or even absent in healthy tissues and cells because it is not essential to life. 24 Multiple clinical studies have revealed a strong expression of RAGE in various malignancies such as gastric, 18 liver, 25 pancreatic, 26 colon, 17, 27 and prostate 16 cancers. Herein, we observed both intracellular and extracellular RAGE expressions in cervical squamous cancer cells, with the highest in SiHa cells and lowest in CaSki cells. Therefore, SiHa cells were selected to explore the influence of RAGE inhibition on its growth and apoptosis. Using the specific inhibitor (FPS-ZM1) of RAGE, the proliferation was significantly suppressed in a timeand dose-dependent way and the apoptosis was also induced in a dose-dependent manner in SiHa cells. PCNA is a nuclear protein and is essential for DNA replication and repair, whose overexpression represents the abnormal cell proliferation. 28 Additionally, the Bax/ Bcl-2 ratio is a "rheostat" that regulates cell death. Under the stimulation of external factors, cell death ultimately depends on the balance between Bax and Bcl-2 expression. 6, 29 Moreover, these results were further confirmed by Western blotting analysis showing a decreased expression of PCNA and an increased Bax/Bcl-2 ratio. Constien et al 30 have found that mice with RAGEknockout (RAGE −/-) are viable and physiologically normal, suggesting that therapeutic targeting of RAGE may be safe in humans. Indeed, several small-molecule RAGE antagonists have become available in basic researches for treating cancers. 22, 31, 32 Hence, targeting RAGE may also become a promising therapeutic strategy for cervical squamous cancer treatment.
To further investigate the role of RAGE in the development of cervical squamous cancer, we upregulated RAGE in both SiHa and CaSki cells and knocked it down in SiHa cells by lentivirus transfection, respectively. Previous studies have shown that increased RAGE expression significantly promotes the proliferation of vascular smooth muscle cells. 33 Furthermore, similar to the growth-promoting function of RAGE in colon, 34 endometrial, 22 pancreatic, 35 and nonsmall cell lung 36 cancer cells, our present results showed that RAGE overexpression significantly promoted cell proliferation and suppressed apoptosis of SiHa and CaSki cells, whereas knockdown of RAGE resulted in opposite biological processes in SiHa cells. Subsequently, SiHa cells xenografts with RAGE overexpression and knockdown in female nude mice were used to explore the function of RAGE in cervical squamous cancer in vivo. Results showed that mice inoculated with RAGE-overexpressing SiHa cells displayed a significant tumor volume from 6 weeks onward. Conversely, RAGE silencing led to a remarkably reduced the tumor volume in xenograft mice at the beginning of 4 weeks. Further, the mechanism of RAGE involved in proliferation and apoptosis were explored in our study. As shown, overexpression of RAGE significantly increased the expression level of PCNA protein and decreased the Bax/Bcl-2 ratio in both SiHa and CaSki cells, which were reversed in RAGE-knockdown SiHa cells. Similarly, SiHa cells xenografts with RAGE overexpression in female nude mice exhibited increased PCNA expression detected by IHC and decreased apoptosis detected by TUNEL assay. SiHa cells xenografts with RAGE knockdown resulted in decreased PCNA expression and increased apoptosis. However, the precise molecular pathway by which RAGE regulates cervical cancer cell growth and apoptosis remains still unclear.
There is mounting evidence suggesting that the PI3K/ AKT signaling pathway plays an indispensable role in the regulation of cellular features such as survival, proliferation, and apoptosis. 37 The research of Tian et al 38 shows the PI3K/AKT pathway is involved in lung cancer cell proliferation and apoptosis. Fang et al 37 reveal that PI3K/ AKT signaling pathway plays an important role in kidney cell apoptosis. Another research demonstrates that radiation could promote cancer cell survival through activating the PI3K/AKT pathway. 39 Our results showed overexpression of RAGE intensively activated PI3K/AKT in both SiHa and CaSki cells and knockdown of RAGE inhibited PI3K/AKT phosphorylation in SiHa cells. To further analyze the role of PI3K/AKT signaling pathway on RAGEmediated proliferation and apoptosis in cervical squamous cancer cells, PI3K/AKT specific inhibitor LY294002 was applied. As seen, LY294002 effectively inhibited RAGEinduced PI3K/AKT activation. In the meantime, PI3K/ AKT inhibition downregulated PCNA protein level along with a decrease of Bcl-2 protein level that resulted in upregulation of Bax/Bcl-2 ratio. Flow cytometry results further confirmed the ability of LY294002 on reversing RAGE overexpression-related apoptosis inhibition. Collectively, these results suggested that PI3K/AKT activation may be responsible for RAGE-mediated proliferation and apoptosis inhibition in cervical squamous cancer cells. Indeed, RAGE could also exert its oncogenic role through a variety of molecular mechanisms. For example, Lan et al 35 find that knockdown of RAGE expression by RAGE-specific siRNA transfection significantly increased cell death through suppressing the PI3K/AKT/mTOR axis. One group has demonstrated that RAGE mediates S100B ability of stimulating colon adenocarcinoma Caco-2 cells proliferation via RAGE/pAKT/mTOR pathway. 34 In addition, the study of Wu et al 40 shows HMGB1/RAGE axis is responsible for renal cell carcinoma apoptosis. Luo et al 41 reported that miR-328-5p regulates breast cancer proliferation and apoptosis through inhibition of RAGE.
However, there are several limitations existing in our study that need to be discussed. First, we need clinical samples to confirm the results that RAGE is responsible for cervical squamous cancer cell proliferation and apoptosis. Second, an in-depth research is needed to study the role of RAGE in cervical squamous cancer bio-behaviors. Taken above, we concluded that overexpression of RAGE promoted proliferation and inhibited apoptosis, conversely, knockdown of RAGE repressed proliferation and induced apoptosis in cervical squamous cancer. Moreover, the specific RAGE inhibitor FPS-ZM1 effectively inhibited proliferation and induced apoptosis in cervical squamous cancer cell. These findings may provide an important mechanism through which RAGE promotes cervical cancer development and provides an alternative target for clinical treatment of cervical squamous cancer. In spite of all these results, the upstream genes or factors of RAGE are still needed to be explored.
Conclusions
In summary, our data demonstrate that RAGE plays an important role in cervical squamous cancer cells proliferation and apoptosis. Further, the experiments reveal that RAGE promotes the growth ability of cervical squamous cell carcinoma by inducing PCNA expression and inhibiting cell apoptosis via the PI3K/AKT pathway.
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